The American College of Rheumatology and National Psoriasis Foundation released new guidelines on the management of active psoriatic arthritis among treatment‐naïve individuals.

FDA Alerts

FDA Alerts
Tuesday, January 2, 2018
The FDA has approved a generic topical solution for the treatment of chronic, moderately severe psoriasis of the scalp.
FDA Alerts
Monday, December 4, 2017
The FDA has expanded the approval of a psoriasis drug to now treat adults with psoriatic arthritis.
FDA Alerts
Monday, October 23, 2017
The FDA has approved extended use of a rheumatoid arthritis drug for the treatment of adult patients with active psoriatic arthritis or active ankylosing spondylitis.
FDA Alerts
Monday, October 16, 2017
The FDA has approved an expanded indication for ustekinumab (Stelara; Janssen) for the treatment of adolescent patients 12 years or older with moderate to severe plaque psoriasis.

News

News
Wednesday, October 17, 2018
Findings from a recent study showed potential associations between psoriasis, comorbid conditions, and sexual and erectile dysfunction among patients with this skin condition.
News
Tuesday, September 25, 2018
Researchers investigated whether psoriasis and psoriatic arthritis were associated with elevated mortality risks compared with the general population, and which factors increased this risk.
News
Thursday, September 20, 2018
In a recent study, researchers investigated the risk of developing type 2 diabetes and various cardiovascular diseases among patients with psoriatic arthritis compared with the general population and patients with psoriasis.
News
Wednesday, September 12, 2018
A recent review highlights the most effective, evidence-based complementary and alternative therapies for patients with psoriasis. 

NPF Endorsed Articles

NPF Endorsed Articles
Tuesday, February 27, 2018
The posters presented at The Winter Clinical Dermatology Conference–Hawaii showcased the latest research and management approaches for skin conditions they encounter in clinical practice.
NPF Endorsed Articles
Tuesday, December 22, 2015
Researchers conducted a systematic literature review of 73 published studies to identify factors associated with treatment non-adherence across diseases in rheumatology, gastroenterology and dermatology.   
NPF Endorsed Articles
Monday, December 21, 2015
In a study published in American Journal of Clinical Dermatology, researchers analyzed the efficacy of adalimumab (Humira, AbbVie Inc.) in patients with psoriasis who previously received systematic therapy. 
NPF Endorsed Articles
Monday, December 21, 2015
​The prevalence of non-alcoholic fatty liver disease (NAFLD) in psoriasis patients was evaluated in a cross-sectional study, recently published in Journal of the European Academy of Dermatology and Venereology. 

Research in Review

Research in Review
Friday, July 27, 2018
The various presentations of psoriasis can make choosing from among the numerous treatment options overwhelming for patients and physicians. Treatment algorithms can help guide the decision.
Research in Review
Thursday, May 17, 2018
A review of recent news, research, and treatment related to psoriasis.
Research in Review
Tuesday, February 20, 2018
A review of recent news, research, and treatment related to psoriasis
Research in Review
Tuesday, January 9, 2018
The Research Trainee Symposium brings together the sharpest minds in psoriatic disease research.